![How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology](https://ecancer.org/en/journal/article/site/data/images/article/918/can-13-913fig6.gif)
How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology
![Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline☆ - ESMO Open Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline☆ - ESMO Open](https://www.esmoopen.com/cms/asset/950b5682-6414-4bf8-907c-e1daa4859e7f/gr1.jpg)
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline☆ - ESMO Open
![Evaluation of a modified Karnofsky score to assess physical and psychological wellbeing of cats in a hospital setting - Elien RL Taffin, Dominique Paepe, Miguel Campos, Luc Duchateau, Nesya Goris, Katrien De Evaluation of a modified Karnofsky score to assess physical and psychological wellbeing of cats in a hospital setting - Elien RL Taffin, Dominique Paepe, Miguel Campos, Luc Duchateau, Nesya Goris, Katrien De](https://journals.sagepub.com/cms/10.1177/1098612X15610620/asset/images/large/10.1177_1098612x15610620-fig3.jpeg)
Evaluation of a modified Karnofsky score to assess physical and psychological wellbeing of cats in a hospital setting - Elien RL Taffin, Dominique Paepe, Miguel Campos, Luc Duchateau, Nesya Goris, Katrien De
![Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.20.02063/asset/images/large/jco.20.02063f1.jpeg)
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology
![PDF) Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation PDF) Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation](https://www.researchgate.net/publication/250921775/figure/fig1/AS:267491410706461@1440786330728/Proposed-algorithm-system-for-the-evaluation-of-the-Karnofsky-performance-status-The_Q320.jpg)
PDF) Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation
![Cancers | Free Full-Text | Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study Cancers | Free Full-Text | Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study](https://www.mdpi.com/cancers/cancers-11-00128/article_deploy/html/images/cancers-11-00128-g001.png)
Cancers | Free Full-Text | Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study
![A 3-month survival model after Gamma Knife surgery in patients with brain metastasis from lung cancer with Karnofsky performance status ≤ 70 | Scientific Reports A 3-month survival model after Gamma Knife surgery in patients with brain metastasis from lung cancer with Karnofsky performance status ≤ 70 | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-023-40356-6/MediaObjects/41598_2023_40356_Fig1_HTML.png)